🔗 Permalink

Inventor profile of:

David Craig Mc Gowan

City:

Brussels

Country:

Belgium

Published Applications:

Last publication date:

2021-12-16

Top Assignees for applications by David Craig Mc Gowan

The entities that hold a legal rights for patent applications filed by inventor Mc Gowan David Craig:

JANSSEN SCIENCES IRELAND UC 4 Little Island, Co Cork, Ireland
Janssen Sciences Ireland Unlimited Company 2 Ringaskiddy, Co Cork, Ireland
Janssen Sciences Ireland Unlimited Company 2 County Cork, Ireland
Janssen Sciences Ireland UC 2 Co Cork, Ireland
Janssen R&D Ireland 1 , Ireland
JANSSEN SCIENCES IRELAND UC 1 Little Island, Co. Cork, Israel
Janssen Sciences Ireland UC 1 Little Island, Co County, Ireland
Janssen Sciences Ireland UC 1 Eastgate, Little Island, County Cork, Ireland
Janssen Sciences Ireland UC 1 East Gate, Little Island, Co Country, Ireland
JANSSEN SCIENCES IRELAND UNLIMITED COMPANY 1 Ringaskiddy, Co Co, Ireland
Janssen Sciences Ireland Unlimited Company 1 Barnahely Ringaskidd, Ireland
Janssen Infections Diseases BVBA, 1 Beerse, Belgium
Janssen Sciences Ireland Unlimited Company 1 Co Cork, Ireland
Medivir AB 1 , Sweden

Recent patent applications by Mc Gowan David Craig

David Craig Mc Gowan from Brussels, BE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-12-16

US20210387997A1

Chemistry; metallurgy

DIHYDROPYRANOPYRIMIDINES FOR THE TREATMENT OF VIRAL INFECTIONS

#2 | 2021-07-15

US20210214317A1

Chemistry; metallurgy

PYRIMIDINE PRODRUGS FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES

#3 | 2020-07-23

US20200231577A1

Chemistry; metallurgy

Aryl substituted pyrimidines for use in influenza virus infection

#4 | 2020-01-30

US20200031779A1

Chemistry; metallurgy

Pyrimidine prodrugs for the treatment of viral infections and further diseases

#5 | 2020-01-02

US20200002342A1

Chemistry; metallurgy

Pyrrolo [3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases

#6 | 2019-10-24

US20190322678A1

Chemistry; metallurgy

Dihydropyranopyrimidines for the treatment of viral infections

#7 | 2019-10-10

US20190308940A1

Chemistry; metallurgy

2-aminopyrimidine derivatives for the treatment of viral infections

#8 | 2019-02-14

US20190047989A1

Chemistry; metallurgy

Aryl substituted pyrimidines for use in influenza virus infection

#9 | 2017-11-30

US20170342035A1

Chemistry; metallurgy

2-aminopyrimidine derivatives for the treatment of viral infections

#10 | 2017-09-07

US20170253600A1

Chemistry; metallurgy

Pyrrolopyrimidines for use in influenza virus infection

#11 | 2017-08-10

US20170226102A1

Chemistry; metallurgy

Indoles for use in influenza virus infection

#12 | 2016-04-28

US20160115125A1

Chemistry; metallurgy

Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

#13 | 2016-04-21

US20160108021A1

Chemistry; metallurgy

Pyridone derivatives for the treatment of viral infections and further diseases

#14 | 2015-12-31

US20150376140A1

Chemistry; metallurgy

2-aminopyrimidine derivatives for the treatment of viral infections

#15 | 2015-11-26

US20150336955A1

Chemistry; metallurgy

Piperidino-pyrimidine derivatives for the treatment of viral infections

#16 | 2015-10-01

US20150274676A1

Chemistry; metallurgy

Substituted acylaminopyrimidines as inducers of alpha interferon production

#17 | 2014-11-27

US20140350031A1

Chemistry; metallurgy

Piperidino-pyrimidine derivatives for the treatment of viral infections

#18 | 2010-02-18

US20100041728A1

Chemistry; metallurgy

HCV inhibiting macrocyclic phenylcarbamates

InventorID:

984045 ⎘